Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes
GDM 风险、胎儿生长和糖尿病进展的孕前生物标志物
基本信息
- 批准号:8469071
- 负责人:
- 金额:$ 45.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAlcohol consumptionBehavioralBiological MarkersBirthBirth traumaBody Weight ChangesC-reactive proteinCaliforniaChildConceptionsDataDatabasesDevelopmentDiabetes MellitusDiabetes preventionDiagnosisDietDiseaseEarly treatmentEnzymesEthnic OriginEtiologyFamily history ofFetal GrowthFlowchartsFreezingFunctional disorderGamma-glutamyl transferaseGestational AgeGestational DiabetesGlucose IntoleranceGrowthHealthHigh birth weight infantHormonal ChangeIncidenceInfantInflammationInsulin ResistanceKnowledgeLifeLiverLow-Density LipoproteinsMaternal AgeMeasuresMediatingMedical HistoryMetabolicMetabolic PathwayMothersNested Case-Control StudyNon-Insulin-Dependent Diabetes MellitusOGTTObesityOutcomeOxidative StressParticle SizePatient currently pregnantPerinatalPhenotypePhysical activityPhysiologicalPlayPregnancyPreventionPrevention strategyProtein IsoformsRaceResearchRiskRisk FactorsRoleSamplingSerumSmokingTimeUnited StatesVisitWeight GainWhite Blood Cell Count procedureWomanadiponectinalpha-Fetoproteinscheckup examinationcohortfollow-upglucose tolerancehigh riskindexinginflammatory markerinsightinterestmodifiable riskobesity in childrenoffspringparitypreventpublic health relevanceyoung woman
项目摘要
DESCRIPTION (provided by applicant): Gestational diabetes mellitus (GDM) has short and long-term consequences for both the mother and her offspring. Women with GDM are more likely to deliver a large for gestational (LGA) infant and up to 50% of them will develop type 2 diabetes. However, up to half of women with GDM have no known risk factors, suggesting that other factors must be involved. Biomarkers associated with various metabolic pathways (insulin resistance, inflammation and oxidative stress) might be useful for identifying women at risk of GDM who could be targeted for prevention and may also further our understanding of the pathophysiology of GDM and its consequences. The metabolic and hormonal changes intrinsic to pregnancy make it important to assess these metabolic biomarkers before pregnancy to determine the temporal sequence of the associations. In three primary aims we propose to evaluate whether biomarkers of: 1) insulin resistance (adiponectin, HMW adiponectin, Fetuin-A and LDL-C particle size), 2) inflammation (CRP), and 3) oxidative stress (GGT) assessed before pregnancy, are associated with increased risk GDM. We will explore in the secondary aims whether: 4) pregravid levels of adiponectin and its isoforms are associated with the risk of having a LGA infant and whether this association is mediated by GDM; 5) among the women with GDM, pre-gravid levels of biomarkers of insulin resistance, inflammation, and oxidative stress and their long-term changes are associated with T2DM and degree of insulin resistance. We propose a nested case-control study within a multi-ethnic cohort of 4,084 women who took part in the Kaiser Permanente Northern California (KPNC) multiphasic health checkup (MHC) exam between 1984-1996, had serum samples stored, and had a subsequent pregnancy. We will study 235 women with GDM and 470 normoglycemic control women matched on year of MHC exam, age at MHC exam and age at pregnancy. No studies to date have examined biomarkers of metabolic risk before pregnancy and risk of GDM. This study will fill a gap in scientific knowledge by determining if pregravid biomarkers, measured among healthy young women, are associated with the risk of GDM, a metabolic alteration occurring early in life. This research could have translational value in the prevention of GDM its progression to T2DM, and health sequelae in their offspring.
描述(由申请人提供):妊娠期糖尿病(GDM)对母亲及其后代都有短期和长期影响。患有GDM的女性更有可能分娩妊娠期大(LGA)婴儿,其中高达50%的人将发展为2型糖尿病。然而,多达一半的GDM女性没有已知的危险因素,这表明其他因素必须参与。与各种代谢途径(胰岛素抵抗,炎症和氧化应激)相关的生物标志物可能有助于识别GDM风险的女性,这些女性可能是预防的目标,也可能进一步加深我们对GDM及其后果的病理生理学的理解。妊娠固有的代谢和激素变化使得在妊娠前评估这些代谢生物标志物以确定相关性的时间顺序变得重要。在三个主要目标中,我们提出评估以下生物标志物是否与GDM风险增加相关:1)胰岛素抵抗(脂联素、HMW脂联素、胎球蛋白-A和LDL-C颗粒大小),2)炎症(CRP),和3)氧化应激(GGT)。我们将在次要目标中探索:4)妊娠前脂联素及其亚型水平是否与生出LGA婴儿的风险相关,以及这种相关性是否由GDM介导; 5)在GDM女性中,妊娠前胰岛素抵抗、炎症和氧化应激生物标志物的水平及其长期变化与T2 DM和胰岛素抵抗程度相关。我们提出了一个嵌套的病例对照研究,在一个多种族队列的4,084名妇女谁参加了凯撒永久北方加州(KPNC)多相健康检查(MHC)考试之间的1984年至1996年,有血清样本储存,并有随后怀孕。我们将研究235名GDM妇女和470名血糖正常的对照妇女,这些妇女在MHC检查的年份、MHC检查时的年龄和怀孕时的年龄上相匹配。迄今为止,还没有研究检查妊娠前代谢风险和GDM风险的生物标志物。这项研究将填补科学知识的空白,确定在健康年轻女性中测量的妊娠前生物标志物是否与GDM(生命早期发生的代谢改变)的风险相关。这项研究可能在预防GDM发展为T2 DM以及后代健康后遗症方面具有转化价值。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Risk of large-for-gestational-age newborns in women with gestational diabetes by race and ethnicity and body mass index categories.
按种族和体重指数类别划分的妊娠期糖尿病女性生下大于胎龄新生儿的风险。
- DOI:10.1097/aog.0b013e318291b15c
- 发表时间:2013
- 期刊:
- 影响因子:7.2
- 作者:Sridhar,SnehaB;Ferrara,Assiamira;Ehrlich,SamanthaF;Brown,SusanD;Hedderson,MoniqueM
- 通讯作者:Hedderson,MoniqueM
Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy.
- DOI:10.2337/dc13-2229
- 发表时间:2014-07
- 期刊:
- 影响因子:16.2
- 作者:Sridhar SB;Xu F;Darbinian J;Quesenberry CP;Ferrara A;Hedderson MM
- 通讯作者:Hedderson MM
A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes.
- DOI:10.1210/js.2018-00200
- 发表时间:2018-10-01
- 期刊:
- 影响因子:4.1
- 作者:Badon SE;Zhu Y;Sridhar SB;Xu F;Lee C;Ehrlich SF;Quesenberry CP;Hedderson MM
- 通讯作者:Hedderson MM
Maternal gestational weight gain and offspring risk for childhood overweight or obesity.
- DOI:10.1016/j.ajog.2014.02.030
- 发表时间:2014-09
- 期刊:
- 影响因子:9.8
- 作者:Sridhar, Sneha B.;Darbinian, Jeanne;Ehrlich, Samantha F.;Markman, Margot A.;Gunderson, Erica P.;Ferrara, Assiamira;Hedderson, Monique M.
- 通讯作者:Hedderson, Monique M.
Prepregnancy cardiometabolic and inflammatory risk factors and subsequent risk of hypertensive disorders of pregnancy.
- DOI:10.1016/j.ajog.2012.05.017
- 发表时间:2012-07
- 期刊:
- 影响因子:9.8
- 作者:Hedderson, Monique M.;Darbinian, Jeanne A.;Sridhar, Sneha B.;Quesenberry, Charles P.
- 通讯作者:Quesenberry, Charles P.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Monique Marie Hedderson其他文献
Monique Marie Hedderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Monique Marie Hedderson', 18)}}的其他基金
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years
含糖饮料税 3-5 年后对体重和健康结果的影响
- 批准号:
10640865 - 财政年份:2020
- 资助金额:
$ 45.05万 - 项目类别:
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years
含糖饮料税 3-5 年后对体重和健康结果的影响
- 批准号:
10425258 - 财政年份:2020
- 资助金额:
$ 45.05万 - 项目类别:
Impact of Sugary Beverage Taxes on Weight and Health Outcomes after 3-5 Years
含糖饮料税 3-5 年后对体重和健康结果的影响
- 批准号:
10194489 - 财政年份:2020
- 资助金额:
$ 45.05万 - 项目类别:
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women
移动健康干预的集群随机试验,以实现超重/肥胖女性适当的妊娠期体重增加
- 批准号:
10379928 - 财政年份:2019
- 资助金额:
$ 45.05万 - 项目类别:
Cluster randomized trial of a mobile health intervention to achieve appropriate gestational weight gain in overweight/obese women
移动健康干预的集群随机试验,以实现超重/肥胖女性适当的妊娠期体重增加
- 批准号:
10599159 - 财政年份:2019
- 资助金额:
$ 45.05万 - 项目类别:
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes
GDM 风险、胎儿生长和糖尿病进展的孕前生物标志物
- 批准号:
8287537 - 财政年份:2010
- 资助金额:
$ 45.05万 - 项目类别:
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes
GDM 风险、胎儿生长和糖尿病进展的孕前生物标志物
- 批准号:
8114199 - 财政年份:2010
- 资助金额:
$ 45.05万 - 项目类别:
Pregravid biomarkers of GDM risk, fetal growth and progression to diabetes
GDM 风险、胎儿生长和糖尿病进展的孕前生物标志物
- 批准号:
7948659 - 财政年份:2010
- 资助金额:
$ 45.05万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 45.05万 - 项目类别:
Directed Grant